Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Checks diet knowledge and Mediterranean diet habits in people with type 2 diabetes

Uses questionnaires to study diet knowledge in adults with type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Evaluation of Dietary Knowledge and the Habit of Using the Mediterranean Diet in Patients With Diabetes

Key facts

Where
Peschiera del Garda, ItalySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07431359, who can take part

Where in Italy

  • Ospedale P. Pederzoli Casa di Cura Privata S.p.A.Peschiera del Garda, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Casa di Cura Dott. Pederzoli
Trial code
NCT07431359
Record updated
24 February 2026
Original description
The main aim of this study is to evaluate nutritional knowledge and adherence to the Mediterranean diet through the administration of questionnaires in patients with type 2 Diabetes Mellitus belonging to Outpatient Diabetology Service of the Hospital.Read full original descriptionShow less

RELATIONSHIP Between ALimentary Knowledge and Adherence to the Mediterranean Diet in Patients With DIABete Mellito Type 2 Attending an Outpatient Service (REALDIAB)

The main aim of this study is to evaluate nutritional knowledge and adherence to the Mediterranean diet through the administration of questionnaires in patients with type 2 Diabetes Mellitus belonging to Outpatient Diabetology Service of the Hospital.

Inclusion: T2DM in nutritional and/or pharmacological euglycemic treatment (metformin, gliptins, gliflozines, incretin mimetics, pioglitazone); Signing of informed consent.

Exclusion: Patient with Diabetes Mellitus type 1; Patients with insulin T2DM treated.

ClinicalTrials.gov NCT07431359